Business Context and Reporting Period
Company: Supernus Pharmaceuticals, Inc. (SUPN)
Filing Type: Form 8-K (Current Report)
Date of Report: August 18, 2020
Reporting Period: Second Quarter ended June 30, 2020
Context: This filing announces the issuance of a press release regarding Q2 2020 financial results and schedules a conference call for August 19, 2020.
Key Financial Metrics
The provided text serves as a notification of results and does not contain specific financial data points. The filing states that detailed results are furnished in Exhibit 99.1 (Press Release) and incorporated by reference. Consequently, the following metrics are not available in the source text:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt Levels
- Liquidity Position
Material Changes
The filing text does not provide specific numerical comparisons or descriptions of material changes versus the prior comparable period. Investors must refer to the referenced press release (Exhibit 99.1) for year-over-year or quarter-over-quarter analysis.
Guidance, Outlook, and Risks
Forward-Looking Statements: The filing contains forward-looking statements regarding plans, strategies, and intentions, identified by terms such as "believe," "expect," and "anticipate."
Disclaimer: The Company undertakes no obligation to update these statements.
Risk Factors: The filing directs readers to risk factors detailed in the following documents for a comprehensive view of uncertainties:
- Form 10-K for the fiscal year ended December 31, 2019 (filed Feb 28, 2020)
- Form 8-K filed on April 3, 2020
- Form 10-Q filed on May 15, 2020
- Form 10-Q filed on August 17, 2020
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q2 2020 revenue, net loss, and cash position figures.
- Verify the date and time of the conference call (August 19, 2020, 9:00 a.m. ET) and access the webcast archive at www.supernus.com.
- Consult the referenced Form 10-K and 10-Q filings for detailed risk factors and historical financial trends.
- Note that the information in this 8-K is "furnished" and not "filed" for liability purposes under Section 18 of the Exchange Act.